PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$145.41M
Total Shares
2.36M
Net Share Change
-277.8K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$145.41M2.36M shares
TRIM-277.8K(-10.5%)